Prostaglandin E 2 induces contraction of liver myofibroblasts by activating EP 3 and FP prostanoid receptors

British Journal of Pharmacology

Volumn 156, Issue 5, 2009, Pages 835-845

  Ayabe, S ^a   Murata, T ^a   Maruyama, T ^a   Hori, M ^a   Ozaki, H ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

EP 3 receptor; FP receptor; Liver myofibroblast; Prostaglandin E 2; Protein kinase C

Indexed keywords

11 FLUORO 9,15 DIHYDROXY 15 (2 INDANYL) 16,17,18,19,20 PENTANORPROSTA 5,13 DIENOIC ACID; 3 (8 AMINOMETHYL 6,7,8,9 TETRAHYDROPYRIDO[1,2 A]INDOL 10 YL) 4 (1 METHYL 3 INDOLYL) 1H PYRROLE 2,5 DIONE; CALCIUM; E PROSTANOID 3 RECEPTOR; F PROSTANOID RECEPTOR; FURA 2; MESSENGER RNA; ONO AE 248; ONO AE1 259 01; ONO AE1 329; ONO DI 004; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROSTANOID RECEPTOR; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C INHIBITOR; ROTTLERIN; UNCLASSIFIED DRUG; ISOENZYME; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN EP3 RECEPTOR; PROSTAGLANDIN F2ALPHA RECEPTOR; PROSTAGLANDIN RECEPTOR; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; LIVER CELL; MALE; MUSCLE FIBER CONTRACTION; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL SIZE; CELL SURVIVAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FIBROBLAST; LIVER; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CALCIUM; CELL SIZE; CELL SURVIVAL; CELLS, CULTURED; DINOPROSTONE; ENZYME ACTIVATION; FIBROBLASTS; ISOENZYMES; LIVER; MALE; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN; RECEPTORS, PROSTAGLANDIN E;

EID: 66949161577     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2008.00051.x     Document Type: Article

References (51)

1. Alexander SP, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol 153 (Suppl. 2 S1 S209.
2. Bradford BU, Enomoto N, Ikejima K, Rose ML, Bojes HK, Forman DT et al. (1999). Peroxisomes are involved in the swift increase in alcohol metabolism. J Pharmacol Exp Ther 288 : 254 259.
3. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD (2001). Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41 : 661 690.
4. Cheng J, Imanishi H, Iijima H, Shimomura S, Yamamoto T, Amuro Y et al. (2002). Expression of cyclooxygenase 2 and cytosolic phospholipase A(2) in the liver tissue of patients with chronic hepatitis and liver cirrhosis. Hepatol Res 23 : 185 195.
5. Davis RJ, Murdoch CE, Ali M, Purbrick S, Ravid R, Baxter GS et al. (2004). EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries. Br J Pharmacol 141 : 580 585.
6. Desmouliere A, Darby IA, Gabbiani G (2003). Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab Invest 83 : 1689 1707.
7. Devaux Y, Seguin C, Grosjean S, de Talance N, Schwartz M, Burlet A et al. (2001). Retinoic acid and lipopolysaccharide act synergistically to increase prostanoid concentrations in rats in vivo. J Nutr 131 : 2628 2635.
8. Enomoto N, Ikejima K, Yamashina S, Enomoto A, Nishiura T, Nishimura T et al. (2000). Kupffer cell-derived prostaglandin E(2) is involved in alcohol-induced fat accumulation in rat liver. Am J Physiol Gastrointest Liver Physiol 279 : G100 106.
9. Friedman SL (2000). Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275 : 2247 2250.
10. Fujino H, Vielhauer GA, Regan JW (2004). Prostaglandin E2 selectively antagonizes prostaglandin F2alpha-stimulated T-cell factor/beta-catenin signaling pathway by the FPB prostanoid receptor. J Biol Chem 279 : 43386 43391.
11. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G et al. (1994). Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199 : 93 98.
12. Hu KQ (2003). Cyclooxygenase 2 (COX2)-prostanoid pathway andliver diseases. Prostaglandins Leukot Essent Fatty Acids 69 : 329 337.
13. Jadhav V, Jabre A, Lin SZ, Lee TJ (2004). EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries. J Cereb Blood Flow Metab 24 : 1305 1316.
14. Jones RL, Qian YM, Chan KM, Yim AP (1998). Characterization of a prostanoid EP3-receptor in guinea-pig aorta: partial agonist action of the non-prostanoid ONO-AP-324. Br J Pharmacol 125 : 1288 1296.
15. Kawada N, Tran-Thi TA, Klein H, Decker K (1993). The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem 213 : 815 823.
16. Kinnman N, Francoz C, Barbu V, Wendum D, Rey C, Hultcrantz R et al. (2003). The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest 83 : 163 173.
17. Kiriyama M, Ushikubi F, Kobayashi T, Hirata M, Sugimoto Y, Narumiya S (1997). Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 122 : 217 224.
18. Knittel T, Kobold D, Piscaglia F, Saile B, Neubauer K, Mehde M et al. (1999a). Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair. Histochem Cell Biol 112 : 387 401.
19. Knittel T, Kobold D, Saile B, Grundmann A, Neubauer K, Piscaglia F et al. (1999b). Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 117 : 1205 1221.
20. 2+ responses to endothelin-1 and PDGF in liver myofibroblasts during the process of cell differentiation. Br J Pharmacol 151 : 816 827.
21. Laleman W, Landeghem L, Wilmer A, Fevery J, Nevens F (2005). Portal hypertension: from pathophysiology to clinical practice. Liver Int 25 : 1079 1090.
22. 2+ -dependent and -independent pathways are involved in rat hepatic stellate cell contraction and intrahepatic hyperresponsiveness to methoxamine. Am J Physiol Gastrointest Liver Physiol 292 : G556 564.
23. Maruyama T, Murata T, Ayabe S, Hori M, Ozaki H (2008). Prostaglandin D(2) induces contraction via thromboxane A(2) receptor in rat liver myofibroblasts. Eur J Pharmacol 591 : 237 242.
24. 2+]i-independent contractile force generation by rat hepatic stellate cells in response to endothelin-1. Am J Physiol Gastrointest Liver Physiol 290 : G7 13.
25. Mohammed NA, Abd El-Aleem SA, El-Hafiz HA, McMahon RF, El-Aleem SA (2004). Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis. J Clin Pathol 57 : 350 354.
26. Muid RE, Dale MM, Davis PD, Elliott LH, Hill CH, Kumar H et al. (1991). A novel conformationally restricted protein kinase C inhibitor, Ro 31-8425, inhibits human neutrophil superoxide generation by soluble, particulate and post-receptor stimuli. FEBS Lett 293 : 169 172.
27. Narumiya S, Sugimoto Y, Ushikubi F (1999). Prostanoid receptors: structures, properties, and functions. Physiol Rev 79 : 1193 1226.
28. Neuschafer-Rube F, Puschel GP, Jungermann K (1993). Characterization of prostaglandin-F2 alpha-binding sites on rat hepatocyte plasma membranes. Eur J Biochem 211 : 163 169.
29. Neyrinck AM, Margagliotti S, Gomez C, Delzenne NM (2004). Kupffer cell-derived prostaglandin E2 is involved in regulation of lipid synthesis in rat liver tissue. Cell Biochem Funct 22 : 327 332.
30. Pestel S, Jungermann K, Gotze O, Schieferdecker HL (2002). Inhibition by prostaglandin E(2) of anaphylatoxin C5a- but not zymosan-induced prostanoid release from rat Kupffer cells. Lab Invest 82 : 463 471.
31. Pinzani M, Milani S, De Franco R, Grappone C, Caligiuri A, Gentilini A et al. (1996). Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 110 : 534 548.
32. Planaguma A, Claria J, Miquel R, Lopez-Parra M, Titos E, Masferrer JL et al. (2005). The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation. FASEB J 19 : 1120 1122.
33. Qian YM, Jones RL, Chan KM, Stock AI, Ho JK (1994). Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery. Br J Pharmacol 113 : 369 374.
34. Ramadori G, Saile B (2002). Mesenchymal cells in the liver - one cell type or two? Liver 22 : 283 294.
35. Ramm GA, Li L, Britton RS, O'Neill R, Bacon BR (2003). Effect of protein kinase C activation and inhibition on rat hepatic stellate cell activation. Dig Dis Sci 48 : 790 796.
36. Reynaert H, Vaeyens F, Qin H, Hellemans K, Chatterjee N, Winand D et al. (2001). Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1. Gastroenterology 121 : 915 930.
37. Reynaert H, Thompson MG, Thomas T, Geerts A (2002). Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut 50 : 571 581.
38. Saile B, Matthes N, Neubauer K, Eisenbach C, El-Armouche H, Dudas J et al. (2002). Rat liver myofibroblasts and hepatic stellate cells differ in CD95-mediated apoptosis and response to TNF-alpha. Am J Physiol Gastrointest Liver Physiol 283 : G435 444.
39. Sandulache VC, Parekh A, Li-Korotky HS, Dohar JE, Hebda PA (2006). Prostaglandin E2 differentially modulates human fetal and adult dermal fibroblast migration and contraction: implication for wound healing. Wound Repair Regen 14 : 633 643.
40. Shah V, Garcia-Cardena G, Sessa WC, Groszmann RJ (1998). The hepatic circulation in health and disease: report of a single-topic symposium. Hepatology 27 : 279 288.
41. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83 : 1325 1358.
42. Steinberg SF (2004). Distinctive activation mechanisms and functions for protein kinase Cdelta. Biochem J 384 : 449 459.
43. Sugimoto Y, Narumiya S (2007). Prostaglandin E receptors. J Biol Chem 282 : 11613 11617.
44. Takahashi A, Camacho P, Lechleiter JD, Herman B (1999). Measurement of intracellular calcium. Physiol Rev 79 : 1089 1125.
45. Tangkijvanich P, Tam SP, Yee HF Jr. (2001). Wound-induced migration of rat hepatic stellate cells is modulated by endothelin-1 through rho-kinase-mediated alterations in the acto-myosin cytoskeleton. Hepatology 33 : 74 80.
46. Tateaki Y, Ogawa T, Kawada N, Kohashi T, Arihiro K, Tateno C et al. (2004). Typing of hepatic nonparenchymal cells using fibulin-2 and cytoglobin/STAP as liver fibrogenesis-related markers. Histochem Cell Biol 122 : 41 49.
47. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA (2002). Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3 : 349 363.
48. Vary TC, Goodman S, Kilpatrick LE, Lynch CJ (2005). Nutrient regulation of PKCepsilon is mediated by leucine, not insulin, in skeletal muscle. Am J Physiol Endocrinol Metab 289 : E684 694.
49. Ward JP, Knock GA, Snetkov VA, Aaronson PI (2004). Protein kinases in vascular smooth muscle tone - role in the pulmonary vasculature and hypoxic pulmonary vasoconstriction. Pharmacol Ther 104 : 207 231.
50. Way KJ, Chou E, King GL (2000). Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol Sci 21 : 181 187.
51. Yamamoto H, Kondo M, Nakamori S, Nagano H, Wakasa K, Sugita Y et al. (2003). JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1. Gastroenterology 125 : 556 571.